CIK 0000944809 · Accelerated filer
OPKO HEALTH, INC.
Sign in to watch- Ticker
- OPK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 752402409
- Phone
- 305-575-4181
- Business address
- 4400 BISCAYNE BLVD., MIAMI, FL, 33137
- Former names
- EXEGENICS INC, eXegenics Inc, CYTOCLONAL PHARMACEUTICS INC /DE
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $24,577
- in 1 filing
Net −$24,577. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-04-10 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +125,000 | $1.36 | $170K | 214,001,448 |
| 2025-04-08 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +125,000 | $1.48 | $185K | 213,876,448 |
| 2025-04-01 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +100,000 | $1.65 | $165K | 213,751,448 |
| 2025-03-28 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +150,000 | $1.70 | $254K | 213,651,448 |
| 2025-03-17 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +200,000 | $1.74 | $348K | 213,501,448 |
| 2025-03-04 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase · 3.75% Convertible Notes due 2029 | +0 | $436,500.00 | $0 | |
| 2025-03-03 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase · 3.75% Convertible Notes due 2029 | +0 | $1,703,250.00 | $0 | |
| 2025-03-03 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase · 3.75% Convertible Notes due 2029 | +0 | $1,707,125.00 | $0 | |
| 2025-02-28 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +67,434 | $1.71 | $115K | 213,301,448 |
| 2025-02-28 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase · 3.75% Convertible Notes due 2029 | +0 | $1,652,750.00 | $0 | |
| 2025-01-28 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +47,537 | $1.47 | $70K | 213,234,014 |
| 2025-01-17 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +150,000 | $1.47 | $220K | 213,186,477 |
| 2025-01-15 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +500,000 | $1.48 | $741K | 213,036,477 |
| 2024-12-13 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +125,000 | $1.60 | $199K | 212,536,477 |
| 2024-12-11 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +500,000 | $1.56 | $781K | 212,411,477 |
| 2024-11-29 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +199,072 | $1.53 | $305K | 211,911,477 |
| 2024-11-22 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +100,000 | $1.59 | $159K | 211,712,405 |
| 2024-11-14 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +100,000 | $1.62 | $162K | 211,612,405 |
| 2024-11-08 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +280,183 | $1.50 | $422K | 211,512,405 |
| 2024-11-08 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +280,183 | $1.50 | $422K | 211,512,405 |
Page 4 of 8 · 159 trades